Alli M. Straubhar
No Rating Available
(Learn About Our Rating System)

Alli M. Straubhar, MD, FACOG

Languages spoken: English

  • Specialties

  • Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Adjunct

    Education history

    Fellowship Gynecologic Oncology - University of Michigan Medical School Fellow
    Fellowship GYN Innovative Surgical Technology Research - Memorial Sloan Kettering Cancer Center Fellow
    Chief Resident Obstetrics & Gynecology - University of Utah School of Medicine Education Chief Resident
    Residency Obstetrics & Gynecology - University of Utah School of Medicine Resident
    Professional Medical Medicine - University of Utah School of Medicine M.D.
    Undergraduate Anthropology/Sociology - College of Idaho B.A.

    Selected Publications

    Journal Article

    1. McLaughlin HD, Greco P, Straubhar AM, Rolston A, McCool K, Brackmann M, Siedel JH, McLean K, Reynolds RK, Uppal S (2023). Implementation of routine venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer. Gynecol Oncol, 178, 89-95. (Read full article)
    2. Straubhar AM, Chan MP, Uppal S (2023). Margin status in vulvovaginal melanoma: Management and oncologic outcomes of 50 cases. Gynecol Oncol Rep, 49, 101268. (Read full article)
    3. Straubhar AM, Zhou Q, Iasonos A, Clarke-Pearson DL, Cliby WA, Hoffman MS, Chi DS (2023). Cross-sectional survey of surgical practices among gynecologic oncologists in the United States. Gynecol Oncol, 172, 36-40. (Read full article)
    4. Straubhar AM, Stroup C, de Bear O, Dalton L, Rolston A, McCool K, Reynolds RK, McLean K, Siedel JH, Uppal S (2023). Provider compliance with a tailored opioid prescribing calculator in gynecologic surgery. Gynecol Oncol, 170, 229-233. (Read full article)
    5. Kahn R, Filippova O, Gordhandas S, An A, Straubhar AM, Zivanovic O, Gardner GJ, OCearbhaill RE, Tew WP, Grisham RN, Sonoda Y, Long Roche K, Abu-Rustum NR, Chi DS (2022). Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors. Gynecol Oncol, 169, 85-90. (Read full article)
    6. Ehmann S, Sassine D, Straubhar AM, Praiss AM, Aghajanian C, Alektiar KM, Broach V, Cadoo KA, Jewell EL, Boroujeni AM, Kyi C, Leitao MM, Mueller JJ, Murali R, Bhaloo SI, OCearbhaill RE, Park KJ, Sonoda Y, Weigelt B, Zamarin D, Abu-Rustum N, Friedman CF (2022). Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers. Gynecol Oncol, 167(3), 458-466. (Read full article)
    7. Rios-Doria E, Filippova OT, Straubhar AM, Chi A, Awowole I, Sandhu J, Broach V, Mueller JJ, Gardner GJ, Jewell EL, Zivanovic O, Leitao MM Jr, Long Roche K, Abu-Rustum NR, Sonoda Y (2022). A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration. Gynecol Oncol, 167(2), 277-282. (Read full article)
    8. Janke MJ, Santiago S, Straubhar AM, Uppal S (2022). The utility of physical examination in ovarian cancer recurrence detection: a retrospective analysis informing virtual surveillance care. Int J Gynecol Cancer, 32(7), 913-917. (Read full article)
    9. Straubhar AM, Chi AJ, Zhou QC, Iasonos A, Filippova OT, Leitao MM Jr, Awowole IO, Abu-Rustum NR, Broach VA, Jewell EL, Sandhu JS, Sonoda Y (2021). Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort. Gynecol Oncol, 163(2), 294-298. (Read full article)
    10. Straubhar AM, Dalton L, Rolston A, McCool K, De Bear O, Stroup C, Reynolds RK, McLean K, Siedel JH, Uppal S (2021). Optimization of postoperative opioid prescriptions in gynecologic oncology: Striking a balance between opioid reduction and pain control. Gynecol Oncol, 162(3), 756-762. (Read full article)
    11. Straubhar AM, Parsons MW, Francis S, Gaffney D, Maurer KA (2021). Refusal of surgery and survival outcomes in endometrial cancer. Int J Gynecol Cancer, 31(9), 1236-1241. (Read full article)
    12. Straubhar AM, Wolf JL, Zhou MQC, Iasonos A, Cham S, Wright JD, Long Roche K, Chi DS, Zivanovic O (2020). Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events. Gynecol Oncol, 160(2), 438-444. (Read full article)
    13. Zivanovic O, Chen LY, Vickers A, Straubhar A, Baser R, Veith M, Aiken N, Carter J, Curran K, Simon B, Mueller J, Jewell E, Chi DS, Sonoda Y, Abu-Rustum NR, Leitao MM Jr (2020). Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study. Gynecol Oncol, 159(1), 187-194. (Read full article)
    14. Straubhar AM, Filippova OT, Cowan RA, Lakhman Y, Sarasohn DM, Nikolovski I, Torrisi JM, Ma W, Abu-Rustum NR, Gardner GJ, Sonoda Y, Zivanovic O, Chi DS, Long Roche K (2020). A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative. Gynecol Oncol, 158(3), 608-613. (Read full article)
    15. Einerson BD, Straubhar A, Soisson S, Szczotka K, Dodson MK, Silver RM, Soisson AP (2018). Hyperglycosylated hCG and Placenta Accreta Spectrum. Am J Perinatol, 36(1), 22-26. (Read full article)
    16. Straubhar A, Soisson AP, Dodson M, Simons E (2017). Successful treatment of low-grade endometrial cancer in premenopausal women with an aromatase inhibitor after failure with oral or intrauterine progesterone. Gynecol Oncol Rep, 21, 10-12. (Read full article)
    17. Stenehjem DD, Toole M, Merriman J, Parikh K, Daignault S, Scarlett S, Esper P, Skinner K, Udager A, Tantravahi SK, Gill D, Straubhar AM, Agarwal AM, Grossmann KF, Samlowski WE, Redman B, Agarwal N, Alva A (2016). Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2. Cancer Immunol Immunother, 65(8), 941-9. (Read full article)
    18. Bailey EB, Tantravahi SK, Poole A, Agarwal AM, Straubhar AM, Batten JA, Patel SB, Wells CE, Stenehjem DD, Agarwal N (2014). Correlation of degree of hypothyroidism with survival outcomes in patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors. Clin Genitourin Cancer, 13(3), e131-7. (Read full article)
    19. Reese Z, Straubhar A, Pal SK, Agarwal N (2015). Ipilimumab in the treatment of prostate cancer. Future Oncol, 11(1), 27-37. (Read full article)
    20. Tantravahi SK, Albertson D, Agarwal AM, Ravulapati S, Poole A, Patel SB, Hawatmeh JS, Straubhar AM, Liu T, Stenehjem DD, Agarwal N (2015). Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma. J Oncol, 2015, 181926. (Read full article)

    Review

    1. Straubhar A, Chi DS, Long Roche K (2021). Update on the role of surgery in the management of advanced epithelial ovarian cancer. [Review]. Clin Adv Hematol Oncol, 18(11), 723-731. (Read full article)